Qlife raises $773,000 in directed share issue, with $350K more proposed
What's the deal? Swedish med-tech group QlifeDealroom has a profile for this one. Try Dealroom → has raised approximately US$930.8K through a directed issue of shares and warrants, with investors including Klockhuset Investment AB and Tellus Equity ABDealroom has a profile for this one. Try Dealroom →. The board upsized the raise from US$725.3K after strong demand in an accelerated bookbuilding run by Fjäll Corporate Finance.
What's the endgame? Qlife makes Egoo, a platform for at-home clinical biomarker and virus testing. The capital is meant to fund its business plan and partner-driven strategy through 2027, as it prepares for a potential move into a larger development program with a global pharmaceutical partner.
Why now? A pharmaceutical partner is funding a product-readiness phase for Egoo, following an earlier feasibility study completed in September 2026. The partner-funded work aims to lay the groundwork for a substantially larger development program — though that step remains conditional.
The board has also called an extraordinary general meeting, planned for December 1, to consider a second directed issue of about US$423.1K (roughly $350,000) proposed by major shareholder JEQ Capital ABDealroom has a profile for this one. Try Dealroom →, aimed at board members, management, and certain consultants. Together, the two issues would raise about US$1.35M before costs.
What could go wrong? Qlife reported just US$229.7K in cash at the end of Q3 and no quarterly revenue, making the raise important for near-term funding. Its March 2026 rights issue took in about US$3.14M but caused significant dilution, and the path to commercial revenue remains unproven.
The signal: The modest, repeated equity raises underline how early-stage med-tech firms lean on partner-funded validation to buy time. For Qlife, the capital and the pharmaceutical tie-up offer a potentially meaningful opportunity — but only if the partner work converts into a committed, larger program.
Read more: placera.se
Image credit: Generated with Gemini
